Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant [NA]
Clinical trial update describing a completed study evaluating blood changes in patients at high risk of cytomegalovirus infection after dono…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Update on a Phase 1 clinical trial of the LMB-2 immunotoxin in young patients with relapsed or refractory leukemia or lymphoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia [Phase 1]
Phase 1 study evaluating UCN-01 in combination with fludarabine for recurrent or refractory leukemia or lymphoma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Immunotoxin in Treating Patients With Leukemia or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update describing an immunotoxin used to treat leukemia or lymphoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Phase 1]
A Phase 1 study sponsored by the National Cancer Institute evaluating arsenic trioxide in pediatric patients with refractory leukemia or lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
A Phase 1 study evaluating perifosine in patients with refractory solid tumors and hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]
Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: New Therapy for Advanced Stage Leukemia After Stem Cell Transplantation [NA]
A clinical trial evaluating a new therapy for advanced-stage leukemia after stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]
This entry notes the completion of a Phase 2 immunosuppressive therapy trial for myelodysplastic syndrome (with leukemia as a listed conditi…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
This completed SWOG trial (NCT00919425) focused on collecting and storing blood and bone marrow samples from patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
A completed SWOG trial (S9007) studying bone marrow and blood samples from patients with leukemia and other hematopoietic cancers.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies [Phase 1]
Phase 1 trial of Actinium-225-labeled HuM195 (lintuzumab) for advanced myeloid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients [NA]
This clinical trial update reports that the ultrasound-assisted lumbar puncture study in pediatric leukemia patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 trial evaluated a reduced-intensity regimen as conditioning before donor bone marrow transplant in patients with myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia [Phase 1]
Phase I study evaluating bevacizumab plus sorafenib with low-dose cyclophosphamide in patients with refractory solid tumors and leukemia has…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes [Phase 1]
Phase I study update reporting completion of MGCD0103 (mocetinostat) given three times weekly in patients with leukemia or myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes [Phase 1]
Phase I study evaluating twice-weekly dosing of MGCD0103 (mocetinostat) in patients with leukemia or myelodysplastic syndromes to assess saf…
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Nutritional Assessment Intervention to Improve Cancer-Related Fatigue [NA]
Clinical trial update on a nutritional assessment intervention intended to improve cancer-related fatigue in patients with leukemia or lymph…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia [Phase 1]
This document reports a completed Phase 1 trial of AT9283 in young patients with relapsed or refractory acute leukemia.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy [Phase 1]
Phase 1 safety study of CLT-008 human myeloid progenitor cells after cord blood transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support [Phase 1]
A Phase 1 pharmacokinetic study of palifermin in patients receiving radiation therapy and chemotherapy followed by autologous blood stem cel…